Literature DB >> 16521869

Prevalence of beta-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia.

Ahmad Al-Suliman1.   

Abstract

BACKGROUND: The Al-Hassa area is one of the regions in Saudi Arabia where hemoglobinopathies are prevalent. The Saudi Ministry Of Heath designed a protocol for premarital testing after the royal decree in December 2003. The protocol was implemented in a February 2004 order. The aim of this study was to determine the prevalence of beta-thalassemia trait among subjects coming for premarital screening in the Al-Hassa area. SUBJECTS AND METHODS: From February 2004 to November 2004, healthy subjects coming to six marriages consultation centers in the Al-Hassa area underwent routine mandatory tests. Subjects were considered to have beta-thalassemia trait if they had a mean corpuscular volume (MCV) <80 fL and/or a mean corpuscular hemoglobin (MCH) <27 pg and a hemoglobin A2 level >3.2%. Venous blood was taken into an EDTA tube and the complete blood count and red blood cell indices were measured by a Coulter automated cell counter on the same day of hemoglobin collection. Electrophoresis was done on cellulose acetate.
RESULTS: All Saudi participants (n=8918), including 4218 (47.3%) males and 4700 (52.7%) females were screened. The prevalence of beta-thassemia trait with high hemoglobin A2 and microcytic hypochromic anemia was 3.4% (307/8918).
CONCLUSION: In countries with a high prevalence of hemoglobinopathies, a premarital screening program is helpful for identification and prevention of high-risk marriages. With a 3.4% prevalence of beta-thalassemia trait in premarital couples, future comprehensive programs are needed to know the actual prevalence of beta-thalassemia in Al-Hassa.

Entities:  

Mesh:

Year:  2006        PMID: 16521869      PMCID: PMC6078547          DOI: 10.5144/0256-4947.2006.14

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


  7 in total

Review 1.  The beta-thalassemias.

Authors:  N F Olivieri
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

2.  Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia.

Authors:  M A el-Hazmi; A S Warsy
Journal:  East Mediterr Health J       Date:  1999-11       Impact factor: 1.628

Review 3.  The thalassaemias.

Authors:  D J Weatherall
Journal:  BMJ       Date:  1997-06-07

Review 4.  Thalassemia: current approach to an old disease.

Authors:  Louise Lo; Sylvia Titi Singer
Journal:  Pediatr Clin North Am       Date:  2002-12       Impact factor: 3.278

5.  Thalassemia syndromes in Saudi Arabia. Meta-analysis of local studies.

Authors:  B H Al-Awamy
Journal:  Saudi Med J       Date:  2000-01       Impact factor: 1.484

6.  Prevalence of thalassaemia in schoolchildren in north-eastern Badia, Jordan.

Authors:  M M Babiker; N Bashir; N Sarsour
Journal:  East Mediterr Health J       Date:  1999-11       Impact factor: 1.628

7.  Molecular diagnosis and carrier screening for beta thalassemia.

Authors:  A Cao; L Saba; R Galanello; M C Rosatelli
Journal:  JAMA       Date:  1997-10-15       Impact factor: 56.272

  7 in total
  7 in total

1.  Epidemiological profile of common haemoglobinopathies in Arab countries.

Authors:  Hanan A Hamamy; Nasir A S Al-Allawi
Journal:  J Community Genet       Date:  2012-12-08

2.  Prevalence of endocrinopathies in patients with Beta-thalassaemia major - a cross-sectional study in oman.

Authors:  Waad-Allah Mula-Abed; Huda Al Hashmi; Muhanna Al Muslahi; Hilal Al Muslahi; Mohammad Al Lamki
Journal:  Oman Med J       Date:  2008-10

3.  Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman.

Authors:  Waad-Allah S Mula-Abed; Huda S Al-Hashmi; Muhanna N Al-Muslahi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

4.  Biochemical and molecular analysis of the beta-globin gene and LCR region on Saudi β-thalassemia patients.

Authors:  Hayat Alafari; Faris Q Alenzi
Journal:  Saudi J Biol Sci       Date:  2020-09-04       Impact factor: 4.219

5.  Undiagnosed Hemoglobinopathies: A potential threat to the premarital screening program.

Authors:  Hassan A Hamali; Muhammad Saboor
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088

6.  Premarital Screening of Beta Thalassemia Minor in north-east of Iran.

Authors:  H Hashemizadeh; R Noori
Journal:  Iran J Ped Hematol Oncol       Date:  2013-01-22

Review 7.  Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf area.

Authors:  Mohamad H Qari; Yasser Wali; Muneer H Albagshi; Mohammad Alshahrani; Azzah Alzahrani; Ibrahim A Alhijji; Abdulkareem Almomen; Abdullah Aljefri; Hussain H Al Saeed; Shaker Abdullah; Ahmad Al Rustumani; Khoutir Mahour; Shaker A Mousa
Journal:  Orphanet J Rare Dis       Date:  2013-09-17       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.